FOXC1 and non-small cell lung carcinoma: Furthermore, a FOXC1 and miR-335-5p network was presented in non-small-cell lung cancer (Mosharaf et al., 2022), type 2 diabetes (Rahman et al., 2020), and vascular dementia (Shu et al., 2022).